---
figid: PMC5709727__EMBJ-36-3501-g013
figtitle: TNF‐p100 pathway subverts noncanonical NF‐KB signaling in inflamed secondary
  lymphoid organs
organisms:
- Mus musculus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
pmcid: PMC5709727
filename: EMBJ-36-3501-g013.jpg
figlink: /pmc/articles/PMC5709727/figure/embj201796919-fig-0007/
number: F7
caption: In resting cells, TRAF2:TRAF3:cIAP complex promotes the degradation of NIK,
  and p100‐IκBδ retains RelB and other NF‐κB monomers. Activation of LTβR leads to
  the proteolysis of TRAF2 and TRAF3 that rescues NIK from the constitutive degradation.
  NIK in association with IKK1 induces the processing of p100 into p52 that liberates
  the RelB heterodimers. TNF signal renders TRAF2 and TRAF3 resistant to degradation
  in LTβR‐stimulated cells resulting in the inactivation of NIK. In addition, TNF‐activated
  RelA dimers induce the transcription of Nfkb2 mRNA, which encodes p100. Therefore,
  TNF treatment of LTβR‐stimulated cells potently accumulates the precursor p100,
  which sequesters the pre‐existing nuclear RelB dimers as inhibitory IκBδ and terminates
  RelB‐mediated expressions of homeostatic chemokines. The proposed mechanism impedes
  continuing ingress of naïve lymphocytes in reactive SLOs.
papertitle: A TNF‐p100 pathway subverts noncanonical NF‐κB signaling in inflamed secondary
  lymphoid organs.
reftext: Tapas Mukherjee, et al. EMBO J. 2017 Dec 1;36(23):3501-3516.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.937382
figid_alias: PMC5709727__F7
figtype: Figure
redirect_from: /figures/PMC5709727__F7
ndex: 836e72b2-df07-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5709727__EMBJ-36-3501-g013.html
  '@type': Dataset
  description: In resting cells, TRAF2:TRAF3:cIAP complex promotes the degradation
    of NIK, and p100‐IκBδ retains RelB and other NF‐κB monomers. Activation of LTβR
    leads to the proteolysis of TRAF2 and TRAF3 that rescues NIK from the constitutive
    degradation. NIK in association with IKK1 induces the processing of p100 into
    p52 that liberates the RelB heterodimers. TNF signal renders TRAF2 and TRAF3 resistant
    to degradation in LTβR‐stimulated cells resulting in the inactivation of NIK.
    In addition, TNF‐activated RelA dimers induce the transcription of Nfkb2 mRNA,
    which encodes p100. Therefore, TNF treatment of LTβR‐stimulated cells potently
    accumulates the precursor p100, which sequesters the pre‐existing nuclear RelB
    dimers as inhibitory IκBδ and terminates RelB‐mediated expressions of homeostatic
    chemokines. The proposed mechanism impedes continuing ingress of naïve lymphocytes
    in reactive SLOs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ltbr
  - Tnfrsf1a
  - Traf2
  - Ikbkg
  - Traf3
  - Tpx2
  - Relb
  - Nfkb1
  - Rela
  - LTBR
  - TNFRSF1A
  - TRAF2
  - TANK
  - IKBKG
  - CHUK
  - IKBKB
  - IKBKE
  - TBK1
  - TRAF3
  - CUX1
  - NFKB2
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - RELB
  - NFKB1
  - RELA
  - REL
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
---
